ROCHESTER, Minn. – Mayo Clinic researchers have identified a protein marker whose frequency may predict patient response to PD-1 blockade immunotherapy for melanoma. An abstractRead more
No posts available.
For Journalists Only Sign up for a Journalist Pass
An online patient support community